# A Bioavailability Study of Two Different PEG-rhGH Preparations.

> **NCT06385145** · PHASE1 · COMPLETED · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Pediatric Growth Hormone Deficiency (PGHD)

## Interventions

- **DRUG:** PEG-rhGH with new preparation (T)
- **DRUG:** PEG-rhGH with present preparation (R)

## Key facts

- **NCT ID:** NCT06385145
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-08
- **Primary completion:** 2024-07-05
- **Final completion:** 2025-03-26
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385145, "A Bioavailability Study of Two Different PEG-rhGH Preparations.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06385145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*